XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Net Sales $ 1,947,052 $ 3,823,334
Cost of Sales 1,228,448 3,052,144
Gross Profit 718,604 771,190
Operating Expenses    
Selling and marketing 411,371 5,620,193
General and administrative 10,997,813 5,079,138
Contract settlement expense 0 4,514,569
Total operating expenses 11,409,184 15,213,900
Operating Loss (10,690,580) (14,442,710)
Other (Expense) Income    
Change in fair value of derivative liabilities 8,883,383 2,331,888
Impairment of patent 0 (130,000)
Impairment of goodwill (1,898,000) 0
Interest (expense) (813,545) (158,419)
Other income (expense) 639,443 (47,902)
Total Other (Expense) Income 6,811,281 1,995,567
NET LOSS (3,879,299) (12,447,143)
Declared Dividends on Preferred Stock 260,688 261,793
Net loss attributable to common stockholders $ (4,139,987) $ (12,708,936)
Net loss per share basic and diluted $ (0.01) $ (0.07)
Weighted average common shares outstanding, basic and diluted 230,204,655 193,799,475